Exposure to 'forever chemicals' before birth linked to higher blood pressure in kids
Forever chemicals have come under growing scrutiny in recent years because they build up in the body and may trigger health problems, according to a growing body of research.
In this new study, Zhang and his team found that when babies were exposed in the womb to specific types of forever chemicals -- PFDeA, PFNA, and PFUnA -- they had higher systolic blood pressure (the top number in a blood pressure reading) later in life, possibly because these chemicals can cross the placenta during pregnancy and affect early development.
MORE: How PFAS are entering America's water supply
"PFAS exposure in the womb can affect fetal growth. There may be potential mechanisms that involve inflammation and oxidative stress that can cause PFAS' long-term health-related changes to blood pressure," Zhang said.
The risk does not affect all children equally. The association was stronger for teens, boys and Black children. In boys, higher exposure to the forever chemical PFDeA was linked to a 9% greater risk of high blood pressure from ages 6 to 12, and a 17% greater risk during the teen years.
Zhang cites previous studies showing that boys could be more sensitive to environmental pollutants due to slower removal rates of toxins from the body and higher rates of buildup.
When it comes to the effect on older children, Zhang speculated that because PFAS stay in the body for so long, it may take longer for their effects to take hold.
Children of Black mothers showed stronger links between PFAS exposure and high blood pressure, which the authors feel may reflect the combined impact of systemic racism, housing segregation and greater environmental exposure.
"We know that due to historic reasons, Black and Hispanic communities face a higher burden of environmental pollutants," he says. Some of the forever chemicals -- including PFHpS, PFOS, and PFOA -- were linked to lower diastolic blood pressure in early childhood, the study found. That's the lower number in a blood pressure reading reflecting when the heart rests between beats. But as kids got older, the effect faded and may have even reversed -- these same chemicals were possibly tied to higher diastolic pressure in adolescence.
MORE: EPA announces limits on some 'forever chemicals,' but just a fraction are covered
Zhang said that these findings matter because children with high blood pressure are much more likely to carry it into adulthood, raising their long-term risk for heart disease, stroke, and kidney problems. Early-life blood pressure patterns can set the stage for serious health issues later on, he noted.
He called for more research into the health effects of forever chemicals as well as policies that focus on reducing their use.
"Meaningful change to reduce PFAS exposure in our daily life requires policy-level change on the state and federal levels," he said. "This will really help the health of children for generations to come."
Dr. Adeiyewunmi (Ade) Osinubi is an emergency medicine resident physician at the University of Pennsylvania and is a member of the ABC News Medical Unit.
Exposure to 'forever chemicals' before birth linked to higher blood pressure in kids originally appeared on abcnews.go.com
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
E&E News
3 hours ago
- E&E News
EPA plans on PFAS spur questions about groundwater
The Trump administration has defended its partial rollback of a federal drinking water rule for 'forever chemicals' by pledging to stop the chemicals from entering water supplies in the first place. But the strategy received mixed reviews recently from state and tribal water officials on an EPA advisory panel. Of particular concern is the fact that preventing new discharges of the chemicals will do little to protect people who rely on groundwater for their drinking water. 'We would not immediately benefit from reducing upstream sources of PFAS,' said Steve Elmore, director of the drinking water program in Wisconsin and chair of EPA's National Drinking Water Advisory Council, during the council meeting last month. 'Most of our contaminated systems are contaminated due to historical processes. They are contaminated now.' Advertisement Used in products like firefighting foam, nonstick pans and carpets, forever chemicals now pollute the drinking water of more than 1 in 3 Americans. Scientists have linked the notoriously indestructible chemicals, or per- and polyfluoroalkyl substances, to a slew of concerning health problems, including cancer.
3 hours ago
ABC News anchor Linsey Davis shares personal struggle with uterine fibroids
ABC News anchor Linsey Davis is opening up for the first time publicly about her yearslong battle with uterine fibroids and her decision to undergo a hysterectomy. Davis, the anchor of "ABC News Live Prime With Linsey Davis" and weekend anchor of "World News Tonight," shared her health journey Monday in a conversation with singer Tamar Braxton and model and actress Cynthia Bailey -- two women who have also spoken publicly about having uterine fibroids -- in hopes of helping even more women. "I feel like if there is an 80% instance in anyone's health, it should be a priority," Davis said of the importance of research into and awareness of uterine fibroids, which the U.S. Office on Women's Health estimates affect up to 80% of women by age 50. Uterine fibroids are muscular tumors -- typically benign -- that grow in or on the wall of the uterus or womb, according to the Office on Women's Health. Fibroids can grow as a single tumor, but are more often found as multiples in the uterus. They can range in size from microscopic to large enough to fill the entire uterus. Some women with fibroids may not experience any symptoms, while other women may experience symptoms including irregular and difficult menstrual cycles, frequent urination, heavy bleeding, cramping and bloating, according to the National Institutes of Health's National Library of Medicine. Davis said that while covering the news in front of the camera, behind the scenes, she has battled painful menstrual cycles, extreme fatigue and severe bloating due to fibroids for years. While covering the Oscars in March, Davis said that bloating she experienced due to fibroids led people to speculate on social media that she was pregnant. "It was such an embarrassing moment ... but it is a pouch that, you know, happens," Davis recalled in her conversation with Bailey and Braxton, who each said they also experienced bloating as a fibroids symptom. "I stayed on the celebrity baby bump alert. Like I was always giving I was pregnant with imaginary children because of my fibroids," Bailey said. "And I was shutting down on rumors, I was like, 'I'm not pregnant, I have fibroids.'" Bailey first publicly shared her fibroids health journey several years ago as a cast member on the reality TV show "The Real Housewives of Atlanta." She is now a paid brand ambassador for USA Fibroid Centers, a "national network of fibroid outpatient centers," according to its website. Braxton, one of the famous Braxton sisters, also opened up publicly several years ago about her battle with fibroids, a condition she says her mom and sisters suffered from as well. All three women spoke about both the physical and mental health challenges they have faced due to fibroids, including pain and fatigue as well as embarrassing moments during their menstrual cycles and feeling like they're falling short in their personal and professional lives. "Not only does it affect you, it affects your family, it affects everybody that's around you, your kids, everyone," Bailey said. "I was exhausted all the time. I was always tired and all I did was work. And when I could just not be present, I would literally just take a shower, get into bed, and just be like, 'Everyone leave me alone now.'" As a young woman, Braxton said she suffered from extreme pain and fatigue during her menstrual cycles, but was not diagnosed with fibroids until later in life when she was trying to become pregnant and had infertility issues. "I became a bit upset at my siblings and my mother," she said, noting that their struggles with fibroids and difficult menstrual cycles were not discussed openly. "I'm like, 'Excuse me, you mean that this is something like I could have prevented or taken care of earlier and I could have understood what was going on with me?' But like we said before … it's a normalized situation, especially in the Black women community." Black women are more likely to develop fibroids than white women, according to the Office on Women's Health, part of the U.S. Department of Health and Human Services. Though fibroids can often be more severe for Black women, they often go undetected until some kind of discomfort begins. In July, tennis star Venus Williams and actress Lupita Nyong'o each publicly revealed their struggles with uterine fibroids, helping to shine a spotlight on the condition among Black women. Dr. Soyini Hawkins, an Atlanta-based board-certified gynecology physician who joined the conversation with Davis, Bailey and Braxton, said there are multiple reasons why Black women are more affected by fibroids. "We know now that there's genetics that go into it. There definitely is a hereditary component for everyone," she said. "And then for us specifically, our melanin blocks vitamin D, and vitamin D is associated with fibroid growth." According to the Office on Women's Health, there is no one specific known cause of uterine fibroids, though they are known to be controlled by hormones. Fibroids tend to worsen when women are in their 30s and 40s, and grow rapidly during pregnancy. Once a woman reaches menopause -- the end of her reproductive years -- fibroids shrink or stop growing. If a fibroid is not causing any symptoms, it may be left untreated and routinely checked by a doctor. Treatment options for fibroids range from options like birth control pills, IUDs, medications and procedures to help ease symptoms. The only cure for fibroids is hysterectomy, a surgery to remove the uterus. Davis, mom of a young son, said that after years of suffering from the symptoms of fibroids and taking into consideration that she may be several years away from the onset of menopause, she decided that hysterectomy was the right treatment option for her. "I guess I just want to be final. You just want to be finished," Davis said. "It causes me enough angst and grief, and, you know, planning my day differently, accordingly, that I really feel like I'm ready to be finished with this journey."
Fox News
10 hours ago
- Fox News
'Missing link' to Alzheimer's disease found in study of human brain tissue
Researchers have uncovered a new factor that could contribute to Alzheimer's disease development. A study by Harvard Medical School has identified low lithium levels in the brain as a possible trigger for the common dementia. Lithium is known to have many functions in the brain, including balancing mood-regulating chemicals, protecting neurons and managing emotional processing. It has also been used to treat bipolar disorder and depression. Now, new findings show that the metal could be a "missing link" in Alzheimer's risk, according to a Harvard press release. The researchers tested lithium's effects in mice, as well as human brain tissue and blood samples. The human brain samples were obtained in partnership with the Rush Memory and Aging Project in Chicago, which maintains post-mortem brain tissue from thousands of donors. The samples represented the full spectrum of cognitive health, ranging from no sign of disease to mild cognitive impairment to advanced Alzheimer's, the release stated. They discovered that lithium levels became lower as signs of the disease increased, showing as "greatly diminished" in advanced Alzheimer's patients. "It's the first time anyone's shown that lithium exists at a natural level that's biologically meaningful without giving it as a drug." As toxic amyloid plaques build up in the brain — a hallmark of Alzheimer's — they begin to attach to lithium, keeping it from performing its protective functions. When the mice were fed a "lithium-restricted diet," their brains' lithium levels decreased, causing accelerated aging, formation of amyloid-beta plaques, greater inflammation, memory loss and cognitive decline. "Lithium turns out to be like other nutrients we get from the environment, such as iron and vitamin C," said senior author Bruce Yankner, professor of genetics and neurology in the Blavatnik Institute at Harvard Medical School, in the release. "It's the first time anyone's shown that lithium exists at a natural level that's biologically meaningful without giving it as a drug." The researchers also discovered a new type of lithium compound — lithium orotate — that did not bind to amyloid. When mice drank water containing this compound, it helped to restore memory and reverse brain damage, even for those who had advanced signs of disease. The findings were published in the journal Nature. "What impresses me the most about lithium is the widespread effect it has on the various manifestations of Alzheimer's," said Yanker. "I really have not seen anything quite like it in all my years of working on this disease." "The idea that lithium deficiency could be a cause of Alzheimer's disease is new and suggests a different therapeutic approach." While the study did suggest that the amount of lithium in the brain could be related to amyloid beta buildup, it did have some obvious limitations, according to Ozama Ismail, Ph.D., director of scientific programs for the Alzheimer's Association in Chicago. "Animal models do not directly replicate Alzheimer's in humans; rather, they can provide some insights into the biology of disease progression and development," Ismail, who was not involved in the study, told Fox News Digital. "The mouse models have been modified to accumulate amyloid beta, a hallmark protein that builds up in the brains of people with Alzheimer's." While studies in mouse models are a "vital early step" in therapeutic research, Ismail emphasized that much more research is needed to understand the health effects of lithium levels in the brain. "Understanding if lithium can be therapeutic for Alzheimer's requires large clinical trials in representative populations," he said. Much like other major diseases, it is likely that Alzheimer's treatment will require multiple approaches combining medication and lifestyle changes, Ismail predicted. The researchers agreed that more research in human clinical trials is needed. "You have to be careful about extrapolating from mouse models, and you never know until you try it in a controlled human clinical trial," Yankner noted. "But so far, the results are very encouraging." If future studies confirm these findings, the scientists say that routine blood tests could potentially screen for lithium levels and identify people at risk. "My hope is that lithium will do something more fundamental than anti-amyloid or anti-tau therapies." In the meantime, Yankner cautioned against people taking lithium compounds "on their own." "My hope is that lithium will do something more fundamental than anti-amyloid or anti-tau therapies, not just lessening but reversing cognitive decline and improving patients' lives," he said. For more health articles, visit The study was supported by the National Institutes of Health, the Ludwig Family Foundation, the Glenn Foundation for Medical Research and the Aging Mind Foundation.
